ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,1517,99517,35719,263
Cost of Revenue17,11330,06833,71724,258
Gross Profit-14,962-22,073-16,360-4,995
Operating Expenses
Research Development13,13713,13713,13713,137
Selling General and Administrative20,76516,60915,59714,203
Non Recurring----
Others----
Total Operating Expenses37,87846,67749,31438,461
Operating Income or Loss-35,727-38,682-31,957-19,198
Income from Continuing Operations
Total Other Income/Expenses Net-11,420-13,527-11,234-4,441
Earnings Before Interest and Taxes-35,727-38,682-31,957-19,198
Interest Expense-12,558-14,037-12,152-5,405
Income Before Tax-47,147-52,209-43,191-23,639
Income Tax Expense2-701-34760
Minority Interest----
Net Income From Continuing Ops-47,149-51,508-43,157-24,399
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-47,149-51,508-43,157-24,399
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-47,149-51,508-43,157-24,399